comprehensive -WSS

comprehensive

author：focus 2025-08-12 09:12:01 - browse：2

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Sanofi seeks simpler, safer CRISPR sickle cell cure

WSS

WHO calls for emergency meeting on new China virus, as cases spread

Why age limits for politicians are a terrible idea

Doctors find melanoma drugs effective against rare brain cancer

Why hospitals are withdrawing from US News rankings

FDA approves RSV monoclonal antibody for infants, toddlers

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

knowledge

comprehensive

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Chemotherapy drug shortage eases slightly but still widespread

Drug repurposing or repositioning? The language matters

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

At least 13 dead in Texas as scorching temps continue

AI can’t replace a physician’s gut feeling

Virginia high school admissions case could be legal follow

Medicare to cover more brain scans for Alzheimer’s patients

Medical leaders decry Supreme Court decision on affirmative action

Sanofi seeks simpler, safer CRISPR sickle cell cure

knowledge

Liquid biopsy for lung cancer is launched by Delfi

Custom gene therapy hints at new path for rare disease treatments

Colorectal cancer study finds potential in overlooked immune cell

How dance can help nurses traumatized by Covid

FDA authorizes Novavax’s updated Covid

In early work, researchers turn to CRISPR to treat Alzheimer's

leisure time

hotspot

leisure time

entertainment